Weather

luni, 28 ianuarie 2019

3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore - Motley Fool

Click to image
  1. 3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore  Motley Fool
  2. Can Gene Editing Concerns Bounce Back?  Seeking Alpha
  3. Forget Humira -- Here's What You Need to Know About AbbVie  The Motley Fool
  4. View full coverage on Google News


from Top stories - Google News Read More
January 28, 2019 at 02:16AM
la
Etichete:

Niciun comentariu:

Trimiteți un comentariu

Abonați-vă la: Postare comentarii (Atom)